Serum immunoglobulin levels and the risk of bladder cancer in the AMORIS Cohort. (2019)
Attributed to:
Preclinical efficacy of an antibody of the IgE class against a melanoma-associated antigen
funded by
MRC
Abstract
No abstract provided
Bibliographic Information
Digital Object Identifier: http://dx.doi.org/10.1016/j.canep.2019.101584
PubMed Identifier: 31451416
Publication URI: http://europepmc.org/abstract/MED/31451416
Type: Journal Article/Review
Volume: 62
Parent Publication: Cancer epidemiology
ISSN: 1877-7821